FI875289A7 - Foerfarande foer framstaellning av kinolinkarboxylsyror. - Google Patents

Foerfarande foer framstaellning av kinolinkarboxylsyror. Download PDF

Info

Publication number
FI875289A7
FI875289A7 FI875289A FI875289A FI875289A7 FI 875289 A7 FI875289 A7 FI 875289A7 FI 875289 A FI875289 A FI 875289A FI 875289 A FI875289 A FI 875289A FI 875289 A7 FI875289 A7 FI 875289A7
Authority
FI
Finland
Prior art keywords
kinolinkarboxylsyror
foerfarande foer
foer framstaellning
framstaellning
foerfarande
Prior art date
Application number
FI875289A
Other languages
English (en)
Finnish (fi)
Other versions
FI875289A0 (fi
Inventor
Michael Priess
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI875289A0 publication Critical patent/FI875289A0/fi
Publication of FI875289A7 publication Critical patent/FI875289A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
FI875289A 1986-12-03 1987-12-01 Foerfarande foer framstaellning av kinolinkarboxylsyror. FI875289A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863641312 DE3641312A1 (de) 1986-12-03 1986-12-03 Verfahren zur herstellung von chinolincarbonsaeuren

Publications (2)

Publication Number Publication Date
FI875289A0 FI875289A0 (fi) 1987-12-01
FI875289A7 true FI875289A7 (fi) 1988-06-04

Family

ID=6315377

Family Applications (1)

Application Number Title Priority Date Filing Date
FI875289A FI875289A7 (fi) 1986-12-03 1987-12-01 Foerfarande foer framstaellning av kinolinkarboxylsyror.

Country Status (25)

Country Link
EP (1) EP0274033B1 (cs)
JP (1) JPS63145268A (cs)
KR (1) KR970005191B1 (cs)
CN (1) CN87107230A (cs)
AT (1) ATE73446T1 (cs)
AU (1) AU593961B2 (cs)
CS (1) CS270577B2 (cs)
DD (1) DD270904A5 (cs)
DE (2) DE3641312A1 (cs)
DK (1) DK174929B1 (cs)
ES (1) ES2038156T3 (cs)
FI (1) FI875289A7 (cs)
GR (1) GR3004301T3 (cs)
HU (1) HU199823B (cs)
IE (1) IE64261B1 (cs)
IL (1) IL84627A (cs)
NO (1) NO174199C (cs)
NZ (1) NZ222736A (cs)
PH (1) PH24489A (cs)
PL (1) PL158614B1 (cs)
PT (1) PT86252B (cs)
SU (1) SU1482526A3 (cs)
UA (1) UA8017A1 (cs)
YU (1) YU45049B (cs)
ZA (1) ZA879040B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN166416B (cs) * 1985-09-18 1990-05-05 Pfizer
WO1990013542A1 (fr) * 1989-04-28 1990-11-15 Daiichi Pharmaceutical Co., Ltd. Medicament anti-hiv
US5385913A (en) * 1989-10-06 1995-01-31 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
WO1991004972A1 (en) * 1989-10-06 1991-04-18 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
JP2613139B2 (ja) * 1990-07-19 1997-05-21 エスエス製薬 株式会社 キノロンカルボン酸誘導体
ES2050613B1 (es) * 1992-10-16 1996-03-16 Iteve S A Nuevo procedimiento para la preparacion de derivados del acido 1-ciclopropil-3-quinolincarboxilico.
US6034100A (en) * 1993-03-10 2000-03-07 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting cytokine secretion
WO1998042341A1 (fr) * 1997-03-25 1998-10-01 Sankyo Company, Limited Agent anti-vif
KR100454750B1 (ko) * 2002-06-20 2004-11-03 삼성에스디아이 주식회사 유기 전계 발광 소자용 청색 발광 화합물 및 이를 사용한유기 전계 발광 소자
PL1666477T3 (pl) 2003-09-10 2013-11-29 Kyorin Seiyaku Kk Pochodna kwasu 7-(4-podstawionego-3-cyklopropyloaminometylo-1- pirolidynylo)chinolonokarboksylowego
JP5322927B2 (ja) 2007-05-24 2013-10-23 杏林製薬株式会社 １４位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体
CN101671302B (zh) * 2008-12-30 2011-03-30 广东海康兽药有限公司 禽畜用抗菌药恩诺沙星的生产工艺
CN101899044B (zh) * 2010-08-16 2012-07-18 常州市勇毅生物药业有限公司 吉米沙星主环化合物的合成方法
CN113912540A (zh) * 2021-12-15 2022-01-11 山东国邦药业有限公司 一种1-环丙基-6,7-二氟-1,4-二氢-4-氧代-3-喹啉甲酸的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5365887A (en) * 1976-11-22 1978-06-12 Kyorin Seiyaku Kk Substituted quinoline*arboxylate and process for preparing same
DE2656574A1 (de) * 1976-12-10 1978-06-15 Schering Ag Neue 1,6-naphthyridincarbonsaeurederivate und verfahren zu ihrer herstellung
JPS53141286A (en) * 1977-05-16 1978-12-08 Kyorin Seiyaku Kk Novel substituted quinolinecarboxylic acid
JPS5845426B2 (ja) * 1978-09-29 1983-10-08 杏林製薬株式会社 置換キノリンカルボン酸誘導体
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
AU553415B2 (en) * 1983-09-19 1986-07-17 Abbott Japan Co., Ltd. 6-fluoro-1-4-dihydro-4-oxo-7-substituted piperazinyl- quinoline-3-carboxylic acids
CA1285279C (en) * 1984-02-17 1991-06-25 Joseph P. Sanchez 7-amine derivatives of 1-cyclopropyl-6,8-difluoro-1,4- dihydro-4-oxo-3-quinolinecarboxylic acids and 1-cyclopropyl-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine- 3-carboxylic acidsas antibacterial agents
DE3420743A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
JPS61205258A (ja) * 1985-03-08 1986-09-11 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体及びその製造方法

Also Published As

Publication number Publication date
CS868887A2 (en) 1989-11-14
FI875289A0 (fi) 1987-12-01
PL269185A1 (en) 1989-01-05
KR970005191B1 (ko) 1997-04-14
NO174199B (no) 1993-12-20
PT86252B (pt) 1990-11-07
PT86252A (en) 1988-01-01
ES2038156T3 (es) 1993-07-16
JPS63145268A (ja) 1988-06-17
EP0274033B1 (de) 1992-03-11
HUT45521A (en) 1988-07-28
UA8017A1 (uk) 1995-12-26
IE873279L (en) 1988-06-03
DK633187A (da) 1988-06-04
YU45049B (en) 1991-06-30
HU199823B (en) 1990-03-28
DD270904A5 (de) 1989-08-16
YU215687A (en) 1988-10-31
NZ222736A (en) 1990-08-28
SU1482526A3 (ru) 1989-05-23
NO174199C (no) 1994-04-06
DK174929B1 (da) 2004-03-01
CN87107230A (zh) 1988-07-06
ZA879040B (en) 1988-05-26
ATE73446T1 (de) 1992-03-15
IL84627A (en) 1992-01-15
DE3641312A1 (de) 1988-06-09
EP0274033A1 (de) 1988-07-13
IL84627A0 (en) 1988-04-29
PH24489A (en) 1990-07-18
PL158614B1 (pl) 1992-09-30
AU8217787A (en) 1988-06-09
NO874788L (no) 1988-06-06
DK633187D0 (da) 1987-12-02
NO874788D0 (no) 1987-11-17
GR3004301T3 (cs) 1993-03-31
DE3777370D1 (de) 1992-04-16
AU593961B2 (en) 1990-02-22
CS270577B2 (en) 1990-07-12
IE64261B1 (en) 1995-07-26
KR880007472A (ko) 1988-08-27

Similar Documents

Publication Publication Date Title
FI870296A7 (fi) Anordning foer faestande av en ledbands- och senprotes.
FI871614A7 (fi) Foerfarande foer aotervinning av svavel fraon svavelhaltiga gaser.
FI873795L (fi) Foerfarande foer framstaellning av integrerade kretsar.
FI870641L (fi) Braennare foer smaeltning av glasmaengd.
FI872528A7 (fi) Emballering av glasfiberisolationsmattor.
FI873654A7 (fi) Maetning av arkmaterial innehaollande fuktskikt.
FI870249A0 (fi) Foerfarande foer torrkationisering av galaktomannaner.
FI82029B (fi) Anordning foer vaermehaerdning av glasskivor.
FI870059A0 (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva aminosyraderivat.
FI875289A7 (fi) Foerfarande foer framstaellning av kinolinkarboxylsyror.
FI864797L (fi) Foerfarande foer framstaellning av en alkoholdryck.
FI880475A0 (fi) Foerfarande foer formattering av faergtelevisionssignaler.
FI870946L (fi) Snabb dna-test foer paovisande av mikrober.
FI863815A7 (fi) En transformationskrets foer utfoerande av rasteroperationer.
FI873190L (fi) Herbicidfoerfarande innefattande anvaendning av diflufenikan.
FI872236L (fi) Foerfarande foer framstaellning av synergistinderivat.
FI870816L (fi) Lackeringsfoerfarande medelst anvaendning av paerlglanspigment.
FI873945L (fi) Foerfarande foer framstaellning av vaermebestaendiga strukturerade skikt.
FI873802A7 (fi) Foerfarande foer framstaellning av benzhydryloxietylpiperidinderivat.
FI873807A0 (fi) Foerfarande foer bindande av lignocellulosamaterial.
FI870132L (fi) Extruderingsverktyg foer framstaellning av en flerskiktig slangfolie.
FI860623A7 (fi) Foerfarande foer framstaellning av fiskfoderpellets.
FI874289A0 (fi) Foerfarande foer framstaellning av traemassa.
FI864909A7 (fi) En baervaogsreglerande koppling av en foer en telefonsystem avsedd fm-syntetisator.
FI873258L (fi) Kontrollanordning foer styrning av multipla lokala naetverk.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: BAYER AKTIENGESELLSCHAFT